BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/3/2026 6:16:25 AM | Browse: 4 | Download: 0
Publication Name World Journal of Psychiatry
Manuscript ID 121038
Country China
Category Psychiatry
Manuscript Type Prospective Study
Article Title Real-world safety and effectiveness of lurasidone in Chinese children and adolescents with schizophrenia: Findings from a prospective cohort
Manuscript Source Unsolicited Manuscript
All Author List Lei Zhang, Yu-Mei Wei and Yi-Feng Shen
Funding Agency and Grant Number
Funding Agency Grant Number
Collaborative Innovation Center Project of Translational Medicine, Shanghai Jiaotong University School of Medicine No. TM202116PT
Clinical Research Plan of SHDC No. SHDC2022CRS032
Sumitomo Pharma (Suzhou) Co.,Ltd
Corresponding Author Yi-Feng Shen, Shanghai Key Laboratory of Psychotic Disorders, Shanghai Clinical Research Center for Mental Health, School of Medicine, Shanghai Jiao Tong University, No. 600 Wanping Nan Road, Shanghai 200030, China. shenyifeng@yahoo.com
Key Words Schizophrenia; Children and adolescents; Lurasidone; Safety; Effectiveness
Core Tip This is the first study to specifically evaluate lurasidone monotherapy in a substantial cohort of Chinese children and adolescents with schizophrenia, providing essential evidence on real-world dosing patterns, safety, and effectiveness. Pediatric patients were initiated on lurasidone at lower doses but underwent more rapid titration, ultimately reaching a slightly higher mean final and daily dose than adults. Lurasidone 40-80 mg/day was well tolerated with low rates of adverse events, suggesting potential clinical improvement, particularly in patients with more severe depressive symptoms. These findings suggest that lurasidone may be a promising treatment option for Chinese pediatric patients with schizophrenia.
Citation Zhang L, Wei YM, Shen YF. Real-world safety and effectiveness of lurasidone in Chinese children and adolescents with schizophrenia: Findings from a prospective cohort. World J Psychiatry 2026; In press
Received
2026-03-16 03:17
Peer-Review Started
2026-03-16 03:19
First Decision by Editorial Office Director
2026-03-20 10:00
Return for Revision
2026-03-20 10:00
Revised
2026-04-16 03:24
Publication Fee Transferred
2026-04-20 06:32
Second Decision by Editor
2026-07-03 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-07-03 06:16
Articles in Press
2026-07-03 06:16
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3206 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com